Active Sites Display

WP_010890696.1:OJAMHIDJ_03821
Sequence length: 469 aa
5 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
IPR000514GHGlycoside hydrolase, family 391–121100%40%11
IPR000974GHGlycoside hydrolase, family 22, lysozyme358–376100%50%21
IPR001329GHGlycoside hydrolase family 56, bee venom hyaluronidase1–1392.9%40%31
IPR017736GHGlycoside hydrolase, family 1, beta-glucosidase9–45892.1%65.4%9158
PF03633GHGlycosyl hydrolase family 65, C-terminal domain1–33395.4%57.1%00
Domain coverage (1–469 aa)
IPR000514 — Glycoside hydrolase, family 39 (domain 1–121)
Cross-ref: InterPro: IPR000514
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 Query: MRHSKLKDFP KDFLWSASTS AYQVEGAWNE DGKGMSVQDA KTSLPEGTSD FKVASDHYHH FEEDIAFLGE MGLKAYRFSI SWTRIIPDGD GKINTKGVQF YHKLIDACLS YNIEPIVTMY HFDLPFELEK KGGWNNRTTI DAFLKFSKIL FEQYGSKVKY FLTINEQNMM ILHGAAIGTS KGSGINIWKE LYQQNHNMLV AQAKAMELCH KLCPNSKIGP APNIASIYPA SSKPEDYLAA QNFTAIRNWL YLDMAVFGRY NSTAWSYLEE IDAVPKIEEG DMEILRNAKP DFIAFNYYNT ATVKANNDAK KVQDSSGDQQ LAVFEAGVFE GVQNPNLEKT EFGWEIDPVG FRITLREVYD RYNLPIIVTE NGLGAFDKLE DGTVHDDYRI EYYKKHLHEI KEAITDGVKV FGYSPWSAID LVSTHQGVTK RYGFIYVNRD EFDLKDLKRY KKDSFYWYKK VIEENGNNL Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·····D···· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········
query > profileD106>D3
IPR000974 — Glycoside hydrolase, family 22, lysozyme (domain 358–376)
Cross-ref: InterPro: IPR000974
GO: GO:0003796 lysozyme activity
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 Query: MRHSKLKDFP KDFLWSASTS AYQVEGAWNE DGKGMSVQDA KTSLPEGTSD FKVASDHYHH FEEDIAFLGE MGLKAYRFSI SWTRIIPDGD GKINTKGVQF YHKLIDACLS YNIEPIVTMY HFDLPFELEK KGGWNNRTTI DAFLKFSKIL FEQYGSKVKY FLTINEQNMM ILHGAAIGTS KGSGINIWKE LYQQNHNMLV AQAKAMELCH KLCPNSKIGP APNIASIYPA SSKPEDYLAA QNFTAIRNWL YLDMAVFGRY NSTAWSYLEE IDAVPKIEEG DMEILRNAKP DFIAFNYYNT ATVKANNDAK KVQDSSGDQQ LAVFEAGVFE GVQNPNLEKT EFGWEIDPVG FRITLREVYD RYNLPIIVTE NGLGAFDKLE DGTVHDDYRI EYYKKHLHEI KEAITDGVKV FGYSPWSAID LVSTHQGVTK RYGFIYVNRD EFDLKDLKRY KKDSFYWYKK VIEENGNNL Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· RC········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········
query > profileR361>R4Y362>C5
IPR001329 — Glycoside hydrolase family 56, bee venom hyaluronidase (domain 1–13)
Cross-ref: InterPro: IPR001329
GO: GO:0004415 hyalurononglucosaminidase activityGO:0006952 defense response
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 Query: MRHSKLKDFP KDFLWSASTS AYQVEGAWNE DGKGMSVQDA KTSLPEGTSD FKVASDHYHH FEEDIAFLGE MGLKAYRFSI SWTRIIPDGD GKINTKGVQF YHKLIDACLS YNIEPIVTMY HFDLPFELEK KGGWNNRTTI DAFLKFSKIL FEQYGSKVKY FLTINEQNMM ILHGAAIGTS KGSGINIWKE LYQQNHNMLV AQAKAMELCH KLCPNSKIGP APNIASIYPA SSKPEDYLAA QNFTAIRNWL YLDMAVFGRY NSTAWSYLEE IDAVPKIEEG DMEILRNAKP DFIAFNYYNT ATVKANNDAK KVQDSSGDQQ LAVFEAGVFE GVQNPNLEKT EFGWEIDPVG FRITLREVYD RYNLPIIVTE NGLGAFDKLE DGTVHDDYRI EYYKKHLHEI KEAITDGVKV FGYSPWSAID LVSTHQGVTK RYGFIYVNRD EFDLKDLKRY KKDSFYWYKK VIEENGNNL Profile: ·CH······· E········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········
query > profileR2>C3H3>H4K11>E12
IPR017736 — Glycoside hydrolase, family 1, beta-glucosidase (domain 9–458)
Cross-ref: InterPro: IPR017736
GO: GO:0008422 beta-glucosidase activityGO:0030245 cellulose catabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 Query: MRHSKLKDFP KDFLWSASTS AYQVEGAWNE DGKGMSVQDA KTSLPEGTSD FKVASDHYHH FEEDIAFLGE MGLKAYRFSI SWTRIIPDGD GKINTKGVQF YHKLIDACLS YNIEPIVTMY HFDLPFELEK KGGWNNRTTI DAFLKFSKIL FEQYGSKVKY FLTINEQNMM ILHGAAIGTS KGSGINIWKE LYQQNHNMLV AQAKAMELCH KLCPNSKIGP APNIASIYPA SSKPEDYLAA QNFTAIRNWL YLDMAVFGRY NSTAWSYLEE IDAVPKIEEG DMEILRNAKP DFIAFNYYNT ATVKANNDAK KVQDSSGDQQ LAVFEAGVFE GVQNPNLEKT EFGWEIDPVG FRITLREVYD RYNLPIIVTE NGLGAFDKLE DGTVHDDYRI EYYKKHLHEI KEAITDGVKV FGYSPWSAID LVSTHQGVTK RYGFIYVNRD EFDLKDLKRY KKDSFYWYKK VIEENGNNL Profile: ·········· ········T· ·Y··E····E D····S··D· ·········· ·D··CDHYHR ··ED······ ·····YR·S· S··R······ ···N······ Y····D···· ·······T·Y H·D······· ······R··· ·····Y···· ·····D···· ··T·NE···· ·········· ···CE····· ·····H···· ·H·······R ·········· ·········· ····ED···· ·········· ·········Y ·········· ·········· D········· D····NYYT· ·········· ·····Y···· ·········· ·········T ·········· ·········· ·Y······TE N·····D··· ·····D··R· ·Y···H···· ·········· K·Y···S··D N·E····Y·K R····Y·DY· T·······R· ·K·S···Y·· ·········
query > profileT19>T11Y22>Y14E25>E17E30>E22D31>D23S36>S28D39>D31K52>D47S55>C50D56>D51H57>H52Y58>Y53H59>H54H60>R55E63>E58D64>D59Y76>Y71R77>R72S79>S74S81>S76R84>R79gap>D88N94>N91Y101>Y98D106>D103T118>T115Y120>Y117H121>H118D123>D120gap>S127gap>D129R137>R138gap>E139F146>Y148S156>D158T163>T165N165>N167E166>E168gap>H182G184>C187I185>E188H196>H199Q202>H205H210>R213gap>Y242gap>K243gap>S245E235>E247D236>D248gap>Y261Y260>Y273D281>D295gap>K304gap>E305gap>N306D291>D311N296>N316Y297>Y317Y298>Y318N299>T319S316>Y336T340>T357Y362>Y380gap>K382T369>T389E370>E390N371>N391D377>D397gap>D407D386>D411R389>R414Y392>Y417H396>H421gap>T430F411>K437Y413>Y439S417>S443D420>D446L421>N447S423>E449V428>Y454K430>K456R431>R457Y436>Y462N438>D464R439>Y465E441>T467R449>R471K452>K474S454>S476Y458>Y480
PF03633 — Glycosyl hydrolase family 65, C-terminal domain (domain 1–333)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 Query: MRHSKLKDFP KDFLWSASTS AYQVEGAWNE DGKGMSVQDA KTSLPEGTSD FKVASDHYHH FEEDIAFLGE MGLKAYRFSI SWTRIIPDGD GKINTKGVQF YHKLIDACLS YNIEPIVTMY HFDLPFELEK KGGWNNRTTI DAFLKFSKIL FEQYGSKVKY FLTINEQNMM ILHGAAIGTS KGSGINIWKE LYQQNHNMLV AQAKAMELCH KLCPNSKIGP APNIASIYPA SSKPEDYLAA QNFTAIRNWL YLDMAVFGRY NSTAWSYLEE IDAVPKIEEG DMEILRNAKP DFIAFNYYNT ATVKANNDAK KVQDSSGDQQ LAVFEAGVFE GVQNPNLEKT EFGWEIDPVG FRITLREVYD RYNLPIIVTE NGLGAFDKLE DGTVHDDYRI EYYKKHLHEI KEAITDGVKV FGYSPWSAID LVSTHQGVTK RYGFIYVNRD EFDLKDLKRY KKDSFYWYKK VIEENGNNL Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········
query > profile
↑ Top





v1.01 @copyright 2026 UCLA